| || |
|PF-___ || ||*__________* Shares|
| || ||Series F Preferred Stock|
SUNESIS PHARMACEUTICALS, INC.
A Delaware Corporation
THIS CERTIFIES THAT *__________* is the record holder of *__________* shares of Series F Convertible Preferred Stock of Sunesis Pharmaceuticals, Inc. transferable only on the books of the Corporation by the holder, in person, or by duly authorized attorney, upon surrender of this certificate properly endorsed or assigned.
This certificate and the shares represented hereby are issued and shall be held subject to all the provisions of the Amended and Restated Certificate of Incorporation, the Certificate of Designation of Preferences, Rights and Limitations of Series F Convertible Preferred Stock, and the Bylaws of the Corporation and any amendments thereto, a copy of each of which is on file at the office of the Corporation and made a part hereof as fully as though the provisions of the Amended and Restated Certificate of Incorporation, the Certificate of Designation of Preferences, Rights and Limitations of Series F Convertible Preferred Stock, and the Bylaws were imprinted in full on this certificate, to all of which the holder of this certificate, by acceptance hereof, assents.
The Corporation will furnish without charge to each stockholder who so requests, the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights.
IN WITNESS WHEREOF, the Corporation has caused this Certificate to be signed by its duly authorized officers this ___ day of July, 2019.
| || || || |
William P. Quinn, Secretary
| || || || |
Dayton Misfeldt, Interim Chief Executive Officer